Evidence map›Paper›PMID 24447640›Full record

ArticleEmerging infectious diseases2014

Fungal endophthalmitis associated with compounded products.

Christina A Mikosz, Rachel M Smith, Moon Kim, Clara Tyson, Ellen H Lee, Eleanor Adams, Susanne Straif-Bourgeois, Rick Sowadsky, Shannon Arroyo, Yoran Grant-Greene and 9 more

Open access · diamondAbstract read
In one paragraph

Article in Emerging infectious diseases, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed, 1 pooled it
8.8field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 1 synthesis or guideline pooled it, 47 citations in OpenAlex.

  1. Pharmaceutical Compounding: a History, Regulatory Overview, and Systematic Review of Compounding Errors.Journal of medical toxicology : official journal of the American College of Medical Toxicology · 2021
    Pooled it
  2. Trial
  3. Review
  4. A pseudo-outbreak ofFrontiers in cellular and infection microbiology · 2023
    Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Review
  11. Endophthalmitis.Korean journal of ophthalmology : KJO · 2017
    Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Endophthalmitis: state of the art.Clinical ophthalmology (Auckland, N.Z.) · 2015
    Review
  19. Fungi associated with drug recalls and rare disease outbreaks.Journal of industrial microbiology & biotechnology · 2014
    Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors at 7 institutions in 1 country.

Christina A Mikosz
Rachel M Smith
Moon Kim
Clara Tyson
Ellen H Lee
Eleanor Adams
Susanne Straif-Bourgeois
Rick Sowadsky
Shannon Arroyo
Yoran Grant-Greene
Julie Duran
Yvonne Vasquez
Byron F Robinson
Julie R Harris
Shawn R Lockhart
Thomas J Török
Laurene Mascola
Benjamin J Park
Fungal Endophthalmitis Outbreak Response Team
Illinois Department of Public Health · USIndiana State Department of Health · USCenters for Disease Control and Prevention · USColorado Department of Public Health and Environment · USNevada Division of Public and Behavioral Health · USNew York State Department of Health · USNew York City Department of Health and Mental Hygiene · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Fungal endophthalmitis is a rare but serious infection. In March 2012, several cases of probable and laboratory-confirmed fungal endophthalmitis occurring after invasive ocular procedures were reported nationwide. We identified 47 cases in 9 states: 21 patients had been exposed to the intraocular dye Brilliant Blue G (BBG) during retinal surgery, and the other 26 had received an intravitreal injection containing triamcinolone acetonide. Both drugs were produced by Franck's Compounding Lab (Ocala, FL, USA). Fusarium incarnatum-equiseti species complex mold was identified in specimens from BBG-exposed case-patients and an unopened BBG vial. Bipolaris hawaiiensis mold was identified in specimens from triamcinolone-exposed case-patients. Exposure to either product was the only factor associated with case status. Of 40 case-patients for whom data were available, 39 (98%) lost vision. These concurrent outbreaks, associated with 1 compounding pharmacy, resulted in a product recall. Ensuring safety and integrity of compounded medications is critical for preventing further outbreaks associated with compounded products.

Indexed as

AgedAged, 80 and overBlindnessDrug RecallsEndophthalmitisEye Infections, FungalFemaleFusariumHumansMaleMiddle AgedOphthalmic SolutionsRetinaRosaniline DyesSaccharomycetalesTriamcinolone Acetonidecoomassie Brilliant BlueOphthalmic SolutionsRosaniline DyesTriamcinolone AcetonideBipolaris hawaiiensiscompoundingdisease outbreaksendophthalmitiseye infectionsFranck’sfungalfungiFusarium incarnatum-equisetimold

Identifiers

PMID24447640
PMCPMC3901475
OpenAlexW2065440789

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.